that JGL continues to invite funds from institutions and not long time shareholders.I am aware of costs that may be incurred but looks as if we always miss out on that 10% discount.Why not have a shareholders plan?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
